Facultad de Medicina y Enfermería
Centro
![Foto de Facultad de Medicina y Enfermería](/img/noimage.png)
![Foto de University of Texas Southwestern Medical Center](/img/noimage_org.png)
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadoras/es de University of Texas Southwestern Medical Center (23)
2023
-
Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository
Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414
-
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
The Lancet Rheumatology
2021
-
Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations
Journal of Neurotrauma, Vol. 38, Núm. 18, pp. 2514-2529
-
Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery
BJS Open
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
-
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder
Nature Communications, Vol. 12, Núm. 1
2019
-
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 7, Núm. 11, pp. 951-963
-
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1
Antiviral Research, Vol. 170
2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
-
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study
The Lancet Neurology, Vol. 17, Núm. 6, pp. 548-558
2017
-
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: A randomised, double-blind, phase III equivalence study
Annals of the Rheumatic Diseases, Vol. 76, Núm. 10, pp. 1679-1687
2016
2014
-
Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials
Diabetes Technology and Therapeutics
-
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Nature Genetics, Vol. 46, Núm. 9, pp. 989-993
-
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
Molecular Cancer, Vol. 13, Núm. 1
2013
-
A novel method that improves sensitivity of protein detection in PAGE and Western blot
Electrophoresis, Vol. 34, Núm. 8, pp. 1148-1150
-
Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicentre, randomised, double-blind, placebo-controlled trials
The Lancet, Vol. 381, Núm. 9881, pp. 1905-1915
-
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
PLoS Medicine, Vol. 10, Núm. 9